Sangamo Therapeutics (SGMOQ) Net Margin Growth (1y) (2011 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Net Margin Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn | 603.00 |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | 2.25 Mn |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | 13,865.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 6,876.00 |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | -67,094.00 |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | -2.38 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 314,889.00 |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn | -3,345.00 |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | 371.00 |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | 9,694.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9,694.00 |
| Sep 30, 2025 | -603,104.00 |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 973,028.00 |
| Dec 31, 2024 | 259,280.00 |
| Sep 30, 2024 | 112,735.00 |
| Jun 30, 2024 | -847,303.00 |
| Mar 31, 2024 | -1.02 Mn |
| Dec 31, 2023 | -276,199.00 |
| Sep 30, 2023 | -90,746.00 |
| Jun 30, 2023 | -152,833.00 |
| Mar 31, 2023 | 16,930.00 |
| Dec 31, 2022 | -5,687.00 |
| Sep 30, 2022 | -3,393.00 |
| Jun 30, 2022 | 2,228.00 |
| Mar 31, 2022 | 1,888.00 |
| Dec 31, 2021 | 2,377.00 |
| Sep 30, 2021 | -16,435.00 |
| Jun 30, 2021 | -237.00 |
| Mar 31, 2021 | 15,384.00 |